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Objective: to evaluate differences in maternal weight gain and fetal cardiac function 
according to exercise during pregnancy 
Methods: A randomized controlled trial was performed at Hospital de Torrejón, Madrid, 
including 120 pregnant women, allocated into Exercise Group (EG) and Control Group 
(CG). The primary outcome was maternal weight. Secondary outcomes included 
caesarean section, preterm delivery, induction of labor, birth weight and fetal cardiac 
function parameters. A sample size of 45 (90 both groups) was planned to detect 
differences in maternal weight gain of at least 1 Kg, with a power of >80% (>0.8) and α 
of .05.  
Results: From November 2014 to June 2015, 205 women were interested in the study 
and 120 were randomized into EG (n=75) and CG (n=45). Characteristics of the study 
participants were similar across groups (maternal age, pre-pregnancy BMI, parity, In 
Vitro Fertilization (FIV), Caucasian, previous to pregnancy physical exercise and 
smoking). No differences were found in maternal weight gain in both groups at 38 
weeks (11.4±4 vs. 11.2±6, p = .82). The rate of a weight loss at 6 weeks postpartum 
was higher in the EG vs. CG (68.2% vs. 42.8%, RR 1.593, p < .05). When analyzing 
fetal cardiac function parameters, the Ductus Arteriosus Pulsatility Index (DA PI) was 
higher at 20 weeks in the EG compared to CG (2.43±0.40 vs. 2.26±0.33, p < .05) and 
the Ejection Fraction (EF) at 36 weeks was higher in the EG vs. CG (0.85±0.13 vs. 
0.81±0.11, p < .05). 
Conclusions: Performing exercise during pregnancy is not associated with a reduction 
in maternal weight gain but a higher weight loss 6 weeks postpartum.  When studying 
fetal cardiac parameters, performing exercise is associated with an increased DAPI at 
20 weeks and EF at 36 weeks, which could translate into adaptive mechanisms. 
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Clinical Trial Registration: Exercise during Pregnancy and Perinatal Outcome. 
URL:https://clinicaltrials.gov/ct2/show/NCT02756143?cond=exercise+and+pregnancy&
draw=2&rank=15. Registration Number: NCT 02756143. 
Introduction 
Maternal pre-pregnancy weight, body mass index (BMI), pattern of gestational weight 
gain, and total gestational weight gain are factors determining birth weight. In addition, 
birth weight and adiposity are important because they have a major impact on neonatal 
morbidity and mortality, and appear to affect early adult weight and long-term 
health{Fraser, 2010, Association of maternal weight gain in pregnancy with offspring 
obesity and metabolic and vascular traits in childhood}. 
The increased gestational weight gain has also been associated with an increased risk 
of cesarean section delivery, pregnancy-related hypertension (gestational 
hypertension, preeclampsia), gestational diabetes1, 2, neonatal adiposity, and childhood 
overweight or obesity. 
Performing exercise during pregnancy has been proved a preventive factor for 
developing hypertension during pregnancy, and there is controversy regarding the 
reduction on excessive gain weight during pregnancy. It may control offspring size at 
birth while reducing comorbidities related to chronic disease risk. 
Regarding the fetus, practicing exercise during pregnancy might increase fetal and 
infant heart rate variability, determine the fetal overall health and the development of 
fetal autonomic nervous system. Fetal cardiac function parameters might also change 
according to the performance of exercise during pregnancy, but so far, it has not yet 
been studied. Also, there are no studies evaluating the association between gestational 
weight gain and fetal cardiac function parameters. During perinatal period, fetal heart 
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could be sensitive to remodeling by environmental factors as has been shown in the 
Intrauterine Growth Restriction (IUGR) fetuses affected by placental insufficiency3. 
The present study aims to clarify if performing a supervised controlled exercise 
program throughout the pregnancy prevents from a gestational weight gain that could 
be associated with a reduction in other pregnancy or birth complications. Secondary 
objective was to analyse caesarean section, preterm delivery, induction of labor, birth 
weight and fetal cardiac function parameters in women performing exercise vs. women 
who do not perform exercise during pregnancy.  
 
Methods 
Participants and trial design: 
A prospective randomized clinical trial was undertaken in Hospital de Torrejón, Madrid, 
Spain. Pregnant women with singleton pregnancies who had a pregnancy follow-up at 
the hospital from the first trimester of pregnancy were given the option of participating 
in the study. Inclusion criteria were: (I) no obstetric or medical complications (based on 
the American college of obstetricians and gynaecologists guidelines (ACOG) 4; (II) time 
of pregnancy <16 weeks; (III) not exercising regularly for more than 30 min (3 
d·week−1); (IV) able to communicate in spanish. Exclusion criteria were: non-
availability to attend to the exercise program during pregnancy. 
Recruitment was performed from November 2014 to June 2015. The trial was 
ended because the sample size was achieved. 
Gestational age was judged from the menstrual history and confirmed by measurement 




Trial coordinators regularly undertook quality control of data handling, and verification 
of adherence to protocols. 
All patients gave written consent. The study was approved by the Local Research 
Ethics Committee of the Hospital (CEIC Hospital Universitario Severo Ochoa) 
(19/07/2013) (Madrid, Spain) and was in accordance with the ethical guidelines of the 
Declaration of Helsinki (modified in 2008). 
The present study has been registered at clinicaltrials.gov identifier NCT 02756143. 
Randomization and masking 
After written informed consent was obtained from women, they were randomly 
allocated to the Exercise Group (EG) or Control Group (CG). A randomization process 
in a 3:5 proportion (for each 3 in the control group, 5 were in the intervention group) 
was used to allocate the study participants. A computer-generated list of random 
numbers was used to allocate the participants into two groups: exercise and control. 
For this EPIDAT 3.1 option of balanced groups (similar but not equal size) was used. 
M.V. was the researcher in charge of generating the random allocation sequence, 
enrolling participants and assigning participants to interventions. 
Intervention 
The EG women undertook a supervised physical conditioning program of three 60 
minutes sessions per week during whole pregnancy (from week 9-38). Each session 
included 10 min of warming up, 25 minutes of cardiovascular exercise, 10 minutes of 
strengthening exercises, 5 minutes of coordination and balance, 5 minutes of pelvic 
floor exercises, and 5 minutes of stretching and relaxation. Aerobic activity was 
prescribed at light to moderate intensity, aiming for 55-60% of maximum heart rate. All 
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subjects wore a heart rate (HR) monitor (Polar FT7) during the training sessions to 
ensure that exercise intensity was mild-moderate.  
The CG women were advised not to attend to any exercise program during pregnancy, 
and in every clinical appointment, women from the CG were interrogated about the 
exercise practice, and was assess that they were not performing a more than 30 
minutes, 3 times per week exercise program. The women were not discouraged from 
exercising on their own. They reported no regular exercise during their pregnancies (by 
telephone interviews). 
The clinical team of the trial in a routine antenatal clinic managed both groups. 
Obstetric Ultrasound was performed at 20, 28 and 36 weeks, including a specific fetal 
echocardiography. The scans were performed by three blind researchers (I.F.B., M.B.S 
y A.M.A.), and data were collected prospectively. An ultrasound system (Voluson s8; 
GE Healthcare) was used accorded with the guidelines of the International Society of 
Ultrasound in Obstetrics and Gynaecology. Women participating in the study received 
general recommendations of nutrition and exercise. 
The following variables were measured by ultrasound in the fetal heart:  
- MPI (Myocardial Performance Index, Tei Index): (ICT + IRT/ET)  
- TAPSE (Tricuspid Annulus Plane Systolic Excursion) 
- MAPSE (Mitral Annulus Plane Systolic Excursion) 
- Tricuspid and Mitral E/A ratios 
- Ejection Fraction ( EF) 
MPI or Tei Index has been assessed using a 2-10 MHz probe. In a four chamber view, 
the calliper was placed in the basal area of left ventricular wall (mitral annulus), 
interventricular sept and right ventricular wall (tricuspid annulus). The insonation angle 
was always < 30º to the ventricular wall. Angle was not corrected. MPI was calculated 
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as following: MPI = (ICT + IRT) / ET. ICT was isovolumetric contraction time, IRT 
isovolumetric relaxation time and ET, cardiac ejection time5. 
TAPSE and MAPSE were calculated in a four chamber apical view, placing the caliper 
in the tricuspid annulum on the right ventricular wall (TAPSE) and in the mitral annulum 
on the left ventricular wall (MAPSE) with an angle of insonation of 0º6. 
In a four chamber view, using Pulsed Doppler though the A-V valves, it was measured 
early (E) and late peaks (A) just underneath the valve outflow and tricuspid and mitral 
E/A ratios were calculated. 
Ejection Fraction was calculated according to the formula EF = (end diastolic 
ventricular volume – end systolic volume) / end diastolic volume. This measure was 
calculated in M-Mode tracing a perpendicular line to the inter-ventricular septal wall in 
2D ultrasound.  
Those women not attending at least 70% of assistance to the program were excluded 
from the final analysis (n=33) in the EG. Women having late miscarriage (n=1) and 
high-risk pregnancy follow–up due to anti –Kell antibodies, were also excluded from the 
CG for the final analysis. 
Outcome measures 
The primary outcome was the maternal weight gain during pregnancy. It was stratified 
as Maternal Weight Gain at 20, 28, 36, and 38 weeks and 6 weeks postpartum. 
Secondary outcomes were: gestational and labour outcomes (Cesarean Section, 
Gestational Age at delivery < 37 weeks, Induction of labor, Birth weight and Perineal 
Tear), perinatal outcome (Birth weight, Apgar score < 6 5th minute, Arterial cord pH 
and Admission to neonatal unit-NNU) and fetal cardiac function parameters (MPI, 
TAPSE, MAPSE, mitral and tricuspid E/A ratios, Aortic and Pulmonary Velocity, Ductus 




Regarding the calculation of sample size, a conservative approach was used. We 
performed a power calculation for the primary outcome, maternal weight gain, 
assuming a bilateral alternative and considering a standard deviation of 2.2 Kg, based 
on the IOM recommendation for pregnancy normal weight 11.5–16 Kg women7. 
Additionally, we wanted to detect differences in maternal weight gain of at least 1 Kg 
with a power of >80% (>0.8) and α of .05. Assuming a maximum loss at follow-up of 
15%, we decided to recruit at least 45 participants for each study group. 
SPPS software package (version 23.0) was used for all statistical analyses. 
Quantitative variables were expressed in mean and standard deviation for EG and GC 
groups and qualitative variables in frequencies and percentages. Comparisons 
between groups were made with the Mann-Whitney U test. Univariate comparisons of 
dichotomous data were done with Fisher’s exact test.  




Baseline characteristics of the study participants 
From November 2014 to June 2015 women were enrolled and randomly assigned to 
perform and supervised exercise program during the pregnancy (EG) or not to perform 
it (CG). From the total eligible population 840 woman, 24.4% women were interested 
on the participation on the study, and 41.4% of them were excluded mainly because of 
non-availability to attend to the exercise program. The baseline characteristics of the 
study eligible women were: maternal age 31,8±5 years old, pre-pregnancy BMI 
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24,8±4,4, nulliparous 54,9%, In Vitro Fertilization (IVF) pregnancies 4,4%, Caucasian 
ethnic 95,7% and smokers 21,7%.  
A total of 120 women were recruited and randomized. Two women were excluded from 
the CG group: a woman because of late miscarriage at 20 weeks and the other 
because of high-risk pregnancy (anti Kell antibody). Also, 33 women from the EG group 
were not compliant with the program, and did not attend to more than 70% of the 
program as requested by the study, and were excluded for the final analysis. Finally, 
the analysis groups were EG (N = 42) and CG (N = 43) shown in the Trial Profile 
(Figure 1). The baseline characteristics were similar between both groups. Regarding 
maternal age, pre-pregnancy BMI, parity, IVF pregnancy, ethnic, previous to pregnancy 
physical exercise and smoking, both groups were homogeneous (Table 1). 
Pregnancy and Perinatal outcomes according to allocation group 
Regarding the primary outcome, maternal weight gain, no differences were found in 
both groups at 20, 28, 36 and 38. However, maternal weight loss at 6 weeks 
postpartum was higher in the EG vs. CG (9.7±3 vs. 8.1±3.5 Kg, p < 0.05). When 
analysing weight loss higher than 9 Kg, the rates were higher for EG vs. CG (68.2% vs. 
42.8%, RR 1.593, 95%CI 1.060-2.393, p < .05). In addition, pregnancy and delivery 
outcomes in both groups were similar in terms of caesarean section, preterm birth <37 
weeks, induction of labour, fetal growth or vaginal tear (Table 2).  
When comparing birth weights, adjusted to gestational age, and calculating centiles of 
birth weight, there were no differences in both groups in birth weight below 10th centile 
in the EC vs. CG ( 16% vs. 18%), p = 0.19). 
Fetal Echocardiography outcomes according to allocation group 
MPI at 20, 28 and 36 weeks of gestation were similar in both groups. In addition, 
TAPSE, MAPSE and Tricuspid E/A Ratio at 20, 28 and 36 weeks were similar in both 
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groups. However, when comparing DA PI was higher in the EG vs. CG (2.43±0.40 vs. 
2.23±0.33, p<.05) and EF at 36 weeks was higher in the EG vs. CG (0.85±0.13 vs. 
0.81±0.11, p < .05). For the rest of the variables aortic artery velocity, pulmonary artery 
velocity, aortic arch PI, no differences were found in both groups in the gestational age 




Main Findings of the Study 
First, the practice of exercise during pregnancy does not reduce maternal weight gain, 
but increases maternal weight loss after delivery. Second, practising exercise during 
pregnancy does not affect the fetal cardiac function. Third, there are changes in the DA 
and EF which could reflect an adaptation in the DA blood flow, increasing the DA PI at 
20 weeks in women exercising compared to the control group, leading to a better EF at 
36 weeks of pregnancy in the exercise group. 
Comparison with previous studies 
Few systematic reviews have studied gestational weight gain and postpartum weight 
loss related to physical activity. The overall findings of a meta-analysis of physical 
activity and weight management in pregnant women suggest that physical activity may 
restrict gestational weight gain. This reduction in maternal weight gain is variable 
according to different studies ranging from 0.50 to 0.80. It is not clear weather this 
reduction is higher in the obese, overweight or normal weight women. Since the 
present study includes mainly normal BMI pre-pregnancy women, this could be the 
rationale for not concordant results. 
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Regarding maternal weight loss in the postpartum period there is one study concluding 
no differences in both groups. The present study shows a higher maternal weight loss 
after delivery in those women exercising during pregnancy. The higher sample size 
could be an explanation for the statistically significant result.  
Regarding the findings of the DA, this vessel is one of the most important vessels of 
the fetal circulation. In the normal developed fetus, 90% of the right ventricular stroke 
volume, is shunted via the DA towards the descending aorta. DA PI does not change 
with gestation, ranging between 1.9 and 3 (mean 2.46 ± 52)8. Under normal conditions, 
the DA has a high level of intrinsic tone during fetal life. The exact underlying 
mechanisms that cause premature constriction of the DA are still subject of 
investigation. Physiologically, the DA remains maximally dilated until term, actively 
sustained by regulatory control of prostaglandins and nitric oxide (NO), which are 
produced within the ductal tissue9.  
Recently, a variety of substances has been identified to exert vasoconstriction on the 
arterial duct, as established for non-esteroid anti-inflammatory drugs. 
Echocardiographic diagnosis of progressive ductal constriction is further based upon 
increased systolic and particularly diastolic peak velocities in the DA, resulting in a PI of 
less than 1.9.  
Pathophysiological basis and insights 
The present study shows that exercise during pregnancy may induce a higher PI in the 
DA at 20 weeks and this effect could be preventive for early closure of DA. This could 
be related to an interaction with the regulatory control of prostaglandins and nitric 
oxide, produced within the ductal tissue. It is reported that acute exercise (as opposed 
to exercise training) in pregnant women is associated with increased sympathoadrenal 
and neurohumoral activity. We hypothesized that these biochemical changes may 
interfere with the control of prostaglandins and nitric oxide within the ductal tissue.  
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Prior to pregnancy, exercise improves oxygenation in muscle and skin but oxygen 
delivery to most viscera falls because of a decrease in blood flow.  During pregnancy 
the exercise effect on visceral flow persists but oxygen delivery to and utilization by the 
feto-placental unit is maintained by several mechanisms which include maternal 
hemoconcentration, and improved perfusion–perfusion balance at the placental 
interphase. Even though oxygen uptake is maintained, the fall in placental bed blood 
flow shifts oxygen delivery to a lower point on the oxyhemoglobin dissociation curve. 
This lowers fetal pO2 which, in the human, initiates a sympathetic response which 
produces an increase fetal heart rate. However, the experimental evidence indicates 
that tissue perfusion and oxygenation must be maintained at normal levels because no 
increased levels of erythropoietin in either cord blood or amniotic fluid have been 
shown.  
The ductus arteriosus is widely patent in fetal life. The factors contributing to the 
maintaining ductal patency in the fetus, include exposure to low partial pressure of 
oxygen, prostaglandins, and local nitric oxide production. Oxygen has been shown to 
constrict the ductus arteriosus in vitro and in vivo10. 
In addition, Fetal Ejection Fraction in exercising pregnant women has not yet been 
investigated. This present randomized controlled trial represents the first time that fetal 
cardiac function has been studied in relation to exercise during pregnancy. Functional 
echocardiography has been demonstrated to select high-risk population and to be 
associated with outcome in several fetal conditions. However, it has not yet been 
incorporated into clinical practice. It is well known that cardiovascular diseases in 
adulthood undergo a long subclinical phase over time, which may start in childhood 
and also in fetal life. Fetal programming of adult cardiovascular diseases occurs when 
a stimulis or an insult in the in utero environment during a sensitive period of 
cardiovascular development permanently alters cardiovascular structure and function. 
Strengths and limitations 
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There are no studies published so far, on which fetal cardiac function parameters have 
been studied in relation to the practice of a supervised program of exercise during 
pregnancy in a randomized controlled trial, and this is the one of the strengths of the 
present research.  
Although the sample size was calculated in order to demonstrate a reduction of 
maternal weight gain in the exercise group, it has proved differences in the ductus 
arteriosus and ejection fraction in both groups studied. The limitation of the present 
study in the size difference between groups, can be explained by the simple 
randomization method used. 
Other limitations of the study are that includes a higher nulliparous population 
compared to the general low risk pregnant population followed in Hospital de Torrejón 
(76,6% vs. 54,9%) and this could represents a selection bias. Also, the study could 
have improved if a special nutritional counselling and follow-up would have been 
assessed, and a questionnaire to assess the physical activity performed in both groups 
was given during the pregnancy.  
 
Conclusions 
In summary, the performance of moderate physical exercise throughout pregnancy 
increases weight loss after delivery, and may induce a beneficial fetal cardiovascular 
development; however, it is still unknown the long term impact. More large prospective 
studies are needed to add knowledge about this fact.  
 
 
Table 1. Characteristics of the study participants 
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Table 2. Pregnancy and Perinatal outcomes according to allocation group 
Table 3. Cardiac function parameters ( MPI, TAPSE, MAPSE, Tricuspid E/A ratio, 
Mitral E/A ratio), Aortic and Pulmonary Velocities and DA and Aortic Arch 
Pulsatility Indexes and Ejection Fraction, according to allocation group. 
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